HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

roquinimex

structure in first source
Also Known As:
LS 2616; LS-2616; Linomide; N-phenylmethyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxoquinoline-3-carboxamide; PNU-212616; 3-Quinolinecarboxamide, 1,2-dihydro-4-hydroxy-N,1-dimethyl-2-oxo-N-phenyl-
Networked: 114 relevant articles (14 outcomes, 27 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hedlund, G: 7 articles (11/2003 - 10/2000)
2. Hedlund, Gunnar: 3 articles (12/2004 - 02/2002)
3. Thorlacius, H: 3 articles (11/2003 - 11/2000)
4. Xiao, Zhi-Yong: 2 articles (12/2007 - 10/2007)
5. Zhang, Yong-Xiang: 2 articles (12/2007 - 10/2007)
6. Yun, Liu-Hong: 2 articles (12/2007 - 10/2007)
7. He, Jun-Feng: 2 articles (12/2007 - 10/2007)
8. Zhou, Wen-Xia: 2 articles (12/2007 - 10/2007)
9. Yang, Ri-Fang: 2 articles (12/2007 - 10/2007)
10. Cheng, Jun-Ping: 2 articles (12/2007 - 10/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Autoimmune Diseases (Autoimmune Disease)
3. Body Weight (Weight, Body)
4. Prostatic Neoplasms (Prostate Cancer)
5. Multiple Sclerosis

Related Drugs and Biologics

1. roquinimex
2. Angiogenesis Inhibitors
3. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
4. Interleukin-10 (Interleukin 10)
5. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
6. Interleukin-4 (Interleukin 4)
7. Pentoxifylline (Trental)
8. Antigens
9. Transforming Growth Factor beta2
10. Cladribine

Related Therapies and Procedures

1. Bone Marrow Transplantation (Transplantation, Bone Marrow)
2. Immunotherapy
3. Photopheresis
4. Immunomodulation
5. Oral Administration